KPC-PRODUCING Serratia marcescens IN A HOME-CARE PATIENT FROM RECIFE, BRAZIL

In this brief communication we describe the occurrence of a KPC-producing Serratia marcescensisolate in a home-care patient from Recife, Brazil. The bla (KPC), bla (SPM), bla (IMP), bla (VIM) bla (OXA), bla (CTX-M), bla (SHV), bla (TEM) and bla (GES) genes were investigated by Polymerase Chain Reaction (PCR) and DNA sequencing. The isolate was positive for bla (KPC-2 )and bla (TEM-1) and was resistant to aztreonam, cefepime, cefotaxime, imipenem, meropenem, gentamicin, ciprofloxacin and cefazidime, and susceptible only to amikacin, tigecycline and gatifloxacin. This is the first report in Brazil of KPC-producing S. marcescens clinical isolate outside of a hospital environment. Caregivers should be alert for the presence of this isolate in the community setting.